Boehringer Ingelheim - researching, developing, manufacturing and marketing of pharmaceuticals

29.04.2012	Switching to TWYNSTA® allows patients with uncontrolled hypertension on monotherapy to rapidly reach their blood pressure goals - For Non-US and Non-UK Healthcare Media Only
24.04.2012	Boehringer Ingelheim on growth path - Successful 2011 financial year
20.04.2012	GLORIA ^TM-AF Registry Program investigating use of antithrombotic therapy in 56,000 patients with atrial fibrillation at risk of stroke announced - For non-US, UK & Canadian Media
19.04.2012	Viral cure achieved without interferon in up to 82% of hepatitis C patients (GT-1a & -1b*) - For media outside of the U.S.A. only
19.04.2012	First ever data investigating interferon-free treatment in hepatitis C patients who have liver cirrhosis shows high viral cure rate - For media outside of the U.S.A. only

Help